What is the global market size of Cell Expansion Market?

Cell Expansion Market size was valued at USD 23.02 billion in 2021 and is poised to grow from USD 25.21 billion in 2022 to USD 47.58 billion by 2030, at a CAGR of 9.5% during the forecast period (2023-2030).

Global Cell Expansion Market Size, Share, Growth Analysis, By Product(Consumables, Culture Flasks & Accessories), By Cell Type(Mammalian, Microbial) - Industry Forecast 2024-2031

Report ID: SQMIG35J2071 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 63 | Figures: 77

Global Cell Expansion Market Competitive Landscape

Cell Expansion Market Top Player’s Company Profiles

Thermo Fisher Scientific Inc. (United States)

Merck KGaA (Germany)

Lonza Group Ltd. (Switzerland)

GE Healthcare (United States)

Sartorius AG (Germany)

Promega Corporation (United States)

Agilent Technologies, Inc. (United States)

Bio-Rad Laboratories, Inc. (United States)

Eppendorf AG (Germany)

Takara Bio Inc. (Japan)

GenScript Biotech Corporation (China)

CellGenix GmbH (Germany)

BD Biosciences (United States)

Novasep Holding S.A.S. (France)

OriGene Technologies, Inc. (United States)

Lonza Biologics Plc (United Kingdom)

Danaher Corporation (United States)

Wuxi AppTec Co., Ltd. (China)

Charles River Laboratories International, Inc. (United States)

Miltenyi Biotec GmbH (Germany)

New England Biolabs, Inc. (United States)

Qiagen N.V. (Netherlands)

Cell Expansion Market Recent Development

In March 2024, CellRev, in partnership with Getinge, launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated with adherent cell culture, Livit ACE reduces costs, enhances productivity and accelerates development times.
In February 2024, Multiply Labs and Thermo Fisher Scientific expanded partnership to automate cell expansion and separation in cell therapy manufacturing.
In September 2023, BioCentriq, Inc. and panCELLa, a Pluristyx Company, signed a research agreement to evaluate the ability of panCELLa's genetically engineered, induced Pluripotent Stem Cell (iPSC)-derived, feeder cells to activate and positively impact the expansion rate, total yield, and potency of manufactured NK cells.
In April 2023, Abbott announced the launch of its new Freestyle Libre 3 continuous glucose monitoring (CGM) system. The Freestyle Libre 3 is a small, wearable sensor that measures blood glucose levels every minute and sends the data to a smartphone app. The system is designed to be more user-friendly and affordable than other CGM systems on the market.
In March 2023, Medtronic announced the launch of its new MiniMed 780G hybrid closed-loop insulin delivery system. The MiniMed 780G system is a combination of an insulin pump and a CGM system that automatically adjusts insulin delivery based on blood glucose levels. The system is designed to help people with type 1 diabetes achieve better glycemic control.

Global Cell Expansion Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cell Expansion Market size was valued at USD 25.21 billion in 2022 and is poised to grow from USD 27.60 billion in 2023 to USD 57.06 billion by 2031, growing at a CAGR of 9.5% during the forecast period (2024-2031).

The global cell expression market is highly competitive and consists of several key players. These players engage in strategies such as collaborations, partnerships, mergers and acquisitions, and product launches to gain a competitive edge. 'Thermo Fisher Scientific Inc. (United States)', 'Merck KGaA (Germany)', 'Lonza Group Ltd. (Switzerland)', 'GE Healthcare (United States)', 'Sartorius AG (Germany)', 'Promega Corporation (United States)', 'Agilent Technologies, Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'Eppendorf AG (Germany)', 'Takara Bio Inc. (Japan)', 'GenScript Biotech Corporation (China)', 'CellGenix GmbH (Germany)', 'BD Biosciences (United States)', 'Novasep Holding S.A.S. (France)', 'OriGene Technologies, Inc. (United States)', 'Lonza Biologics Plc (United Kingdom)', 'Danaher Corporation (United States)', 'Wuxi AppTec Co., Ltd. (China)', 'Charles River Laboratories International, Inc. (United States)', 'Miltenyi Biotec GmbH (Germany)', 'New England Biolabs, Inc. (United States)', 'Qiagen N.V. (Netherlands)'

The continuous advancements in genetic engineering technologies, such as CRISPR/Cas9, have facilitated the development of high-performing cell lines for protein expression. These technologies enable precise modification of cell genomes to enhance protein production, optimize cellular pathways, and improve product quality. The availability of well-characterized and highly productive cell lines contributes to the growth of the cell expression market.

Researchers and scientists are exploring and developing novel expression systems to overcome the limitations of traditional platforms. For instance, cell-free expression systems, including cell-free protein synthesis (CFPS), are gaining attention due to their ability to produce proteins without the need for intact cells. Additionally, synthetic biology approaches are being employed to engineer cell lines with enhanced expression capabilities and more efficient protein production.

With a share of 43.1% in 2023, North America had the greatest proportion. Due to increased government funding initiatives that have sped up the development of regenerative medicine and cellular therapy products as well as the production of stem cells, the region will maintain its leadership position over the future years. As a result, there is a demand for cell expansion platforms in this area. For instance, the FDA and the Medical Technology Enterprise Consortium (MTEC) gave the Southwest Research Institute (SwRI) (U.S.) a total of USD 5.3 million in financing. In order to grow cells for the creation of individualized regenerative medicine, the SwRI invested these monies. The revenue generation in this area is increased by such investments.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Cell Expansion Market Size, Share, Growth Analysis, By Product(Consumables, Culture Flasks & Accessories), By Cell Type(Mammalian, Microbial) - Industry Forecast 2024-2031

Global Cell Expansion Market Competitive Landscape

Global Cell Expansion Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Cell Expansion Market?

Who are the key vendors in the Global Cell Expansion Market?

What is the key driver of Global Cell Expansion Market?

What is the key market trend for Global Cell Expansion Market?

Which region accounted for the largest share in Global Cell Expansion Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300